These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36361535)

  • 1. Pioglitazone Modifies Kupffer Cell Function and Protects against
    Miyazaki H; Kinoshita M; Nakashima H; Nakamura S; Saitoh D
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis.
    Schulte R; Wohlleber D; Unrau L; Geers B; Metzger C; Erhardt A; Tiegs G; van Rooijen N; Heukamp LC; Klotz L; Knolle PA; Diehl L
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARγ activation improves the microenvironment of perivascular adipose tissue and attenuates aortic stiffening in obesity.
    Chen JY; Wu YP; Li CY; Jheng HF; Kao LZ; Yang CC; Leu SY; Lien IC; Weng WT; Tai HC; Chiou YW; Tang MJ; Tsai PJ; Tsai YS
    J Biomed Sci; 2021 Mar; 28(1):22. PubMed ID: 33781257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis.
    Caglayan E; Stauber B; Collins AR; Lyon CJ; Yin F; Liu J; Rosenkranz S; Erdmann E; Peterson LE; Ross RS; Tangirala RK; Hsueh WA
    Diabetes; 2008 Sep; 57(9):2470-9. PubMed ID: 18511847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
    Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
    Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antidepressant-like effects of pioglitazone in a chronic mild stress mouse model are associated with PPARγ-mediated alteration of microglial activation phenotypes.
    Zhao Q; Wu X; Yan S; Xie X; Fan Y; Zhang J; Peng C; You Z
    J Neuroinflammation; 2016 Oct; 13(1):259. PubMed ID: 27716270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented bacterial elimination by Kupffer cells after IL-18 pretreatment via IFN-γ produced from NK cells in burn-injured mice.
    Miyazaki H; Kinoshita M; Ono S; Nakashima M; Hara E; Ohno H; Seki S; Saitoh D
    Burns; 2011 Nov; 37(7):1208-15. PubMed ID: 21696891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
    J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats.
    Kvandova M; Barancik M; Balis P; Puzserova A; Majzunova M; Dovinova I
    J Physiol Pharmacol; 2018 Apr; 69(2):. PubMed ID: 29980143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z; Ye P; Long C; Chen K; Li X; Wang H
    Pharmacology; 2007; 79(3):184-92. PubMed ID: 17356310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture.
    Shimada K; Furukawa H; Wada K; Korai M; Wei Y; Tada Y; Kuwabara A; Shikata F; Kitazato KT; Nagahiro S; Lawton MT; Hashimoto T
    Stroke; 2015 Jun; 46(6):1664-72. PubMed ID: 25931465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone-induced reductions in atherosclerosis occur via smooth muscle cell-specific interaction with PPAR{gamma}.
    Subramanian V; Golledge J; Ijaz T; Bruemmer D; Daugherty A
    Circ Res; 2010 Oct; 107(8):953-8. PubMed ID: 20798360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
    Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
    Grommes C; Landreth GE; Sastre M; Beck M; Feinstein DL; Jacobs AH; Schlegel U; Heneka MT
    Mol Pharmacol; 2006 Nov; 70(5):1524-33. PubMed ID: 16887936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
    Yamanaka M; Ishikawa T; Griep A; Axt D; Kummer MP; Heneka MT
    J Neurosci; 2012 Nov; 32(48):17321-31. PubMed ID: 23197723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype.
    Yamamoto S; Zhong J; Yancey PG; Zuo Y; Linton MF; Fazio S; Yang H; Narita I; Kon V
    Atherosclerosis; 2015 Sep; 242(1):56-64. PubMed ID: 26184694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of peroxisome proliferator-activated receptor γ (PPARγ) Pro12Ala in the Iranian population: relation with insulin resistance and response to treatment with pioglitazone in type 2 diabetes.
    Namvaran F; Azarpira N; Rahimi-Moghaddam P; Dabbaghmanesh MH
    Eur J Pharmacol; 2011 Dec; 671(1-3):1-6. PubMed ID: 21968139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.
    Uchiyama M; Shimizu A; Masuda Y; Nagasaka S; Fukuda Y; Takahashi H
    Mol Vis; 2013; 19():2135-50. PubMed ID: 24194635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
    Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J
    J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation.
    Biscetti F; Straface G; Arena V; Stigliano E; Pecorini G; Rizzo P; De Angelis G; Iuliano L; Ghirlanda G; Flex A
    Cardiovasc Diabetol; 2009 Sep; 8():49. PubMed ID: 19737384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.